Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Subcutaneous Median Nerve Neuromodulation For Drug-Treatment Resistant Hypertension.

NCT02926495 is registered in ClinicalTrials.gov with Valencia Technologies Corporation as lead sponsor.

NCT NCT02926495
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02926495 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Subcutaneous Median Nerve Neuromodulation For Drug-Treatment Resistant Hypertension.
Lead sponsor
Valencia Technologies Corporation
Phase
Not applicable
Overall status
Withdrawn
Start date
November 30, 2016
Completion date
December 31, 2018
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

resistant hypertension